Search

everythinglearnresearchcommunity

for

Search:↓

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Baricitinib was effective in treating both early and late onset alopecia areata.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Tofacitinib may help regrow hair in alopecia areata patients.